| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $17.98M | $22.22M | $17.88M | $14.43M | $12.59M |
| R&D | $11.51M | $16.13M | $11.89M | $8.60M | $7.57M |
| SG&A | $6.46M | $6.09M | $5.98M | $5.83M | $5.02M |
| Operating Income | -$17.98M | -$22.22M | -$17.88M | -$14.43M | -$12.59M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26M | -$12.36M |
| EPS (basic) | -1.5700 | -1.9300 | -1.4700 | -1.3100 | -1.1300 |
| EPS (diluted) | -1.5700 | -1.9300 | -1.4700 | -1.3100 | – |
| Shares (diluted) | $10.90M | $10.76M | $10.84M | $10.85M | – |